Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA expression profiles of BLID shRNA vs. control (scramble) shRNA transduced breast cancer cells

ABSTRACT: Downregulation of BLID in breast cancer has been correlated with poor disease-free survival and overall survival. We used RNA arrays to study the effects of BLID knockdown on gene expression profiles and to identify downstream effectors of BLID in breast cancer cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE295735 | GEO | 2025/06/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

miRNA expression profiles of BLID shRNA vs. control (Scramble) shRNA transduced breast cancer cells

Project description:Downregulation of BLID in breast cancer has been correlated with poor disease-free survival and overall survival. We used miRNA arrays to study the effects of BLID knockdown on miRNA expression profiles in breast cancer cells.

2025-06-11 | GSE295734 | GEO

miRNA expression profiles of BLID shRNA vs. control (Scramble) shRNA transduced breast cancer cells

Project description:miRNA expression profiles of BLID shRNA vs. control (Scramble) shRNA transduced breast cancer cells

| PRJNA1258933 | ENA

RNA expression profiles of BLID shRNA vs. control (scramble) shRNA transduced breast cancer cells

Project description:RNA expression profiles of BLID shRNA vs. control (scramble) shRNA transduced breast cancer cells

| PRJNA1258932 | ENA

Homo sapiens

Project description:Breast cancer relapse free survival

| PRJNA91859 | ENA

Control shRNA- vs. obscurin shRNA-expressing MCF10A cells

Project description:Obscurins (~70-870kDa), encoded by the single OBSCN gene, are cytoskeletal proteins originally identified in striated muscles with structural and regulatory roles. Recently, analysis of 13,023 genes in breast and colorectal cancers identified OBSCN as one of the most frequently mutated genes, implicating it in cancer formation. Herein, we studied the expression profile of obscurins in breast, colon and skin cancer cell lines, and their involvement in cell survival. Immunoblot analysis demonstrated significant reduction of obscurins in cancer cells, resulting from decreased mRNA levels and/or the presence of mutant transcripts. In normal epithelium, obscurins localize in cytoplasmic puncta, the cell membrane and the nucleus. Accordingly, subcellular fractionation demonstrated the presence of two novel nuclear isoforms of ~110 and ~120kDa. Non-tumorigenic MCF10A breast epithelial cells stably transduced with shRNAs targeting giant obscurins exhibited increased viability (~30%) and reduced apoptosis (~20%) following exposure to the DNA damaging agent, etoposide. cDNA microarrays followed by Gene Ontology profiling indicated a substantial number of transcripts related to apoptosis and survival are differentially regulated upon obscurin knock-down. Quantitative RT-PCR further indicated that the anti-apoptotic genes BAG-4 and HAX-1 were up-regulated (1.5 and 1.4 fold, respectively), whereas initiator caspase-9 and death caspase-3 transcripts were down-regulated (0.8 and 0.6 fold, respectively). Our findings are the first to pinpoint critical roles for obscurins in cancer development by contributing to the regulation of cell survival. Two-condition experiment: control shRNA- vs. obscurin shRNA-expressing MCF10A cells exposed to 150 uM etoposide. 3 independent replicates per condition.

2012-02-02 | E-GEOD-35494 | biostudies-arrayexpress

Homo sapiens

Project description:Breast cancer relapse free survival and lung metastasis free survival

| PRJNA96341 | ENA

Control shRNA- vs. obscurin shRNA-expressing MCF10A cells

2012-02-02 | GSE35494 | GEO

Expression data from human breast cancer cell MDA-MB-231 stably expressing MYOSIN10 shRNA versus scramble shRNA

Project description:We used MYOSIN10 shRNA to stably silence the expression of endogenous MYOSIN10 in Breast cancer cell MDA-MB-231. To investigate the inner change of cells with silenced MYOSIN10, we conducted a genome-wide screening for all potential genes affected by MYOSIN10 shRNA using Affymetrix Human Genome U133 plus 2.0 array. We showed genes affected by MYOSIN10 knockdown in breast cancer cell MDA-MB-231

2020-12-31 | GSE52828 | GEO

RNA-Sequencing for pancreatic cancer cells with scramble-shRNA and GPx1-shRNA

Project description:We reported glutathione peroxidase-1 (GPx1) was negatively associated with overall survival in pancreatic ductal adenocarcinoma patients. Silencing GPx1 in pancreatic cancer cells showed epithelial–mesenchymal transition phenotype and increased chemoresistance to gemcitabine in vitro and in vivo. Next, to search for a putative molecular mechanism, we used a high-throughput gene expression profiling array in scramble-shRNA and GPx1-shRNA pancreatic cancer cells (MiaPaCa-2). This study provides the differentially expressed genes and altered signaling pathways towards characterization of gemcitabine resistance cell populations.

2020-10-10 | GSE104962 | GEO

down-regulation of dermcidin by shRNA in breast cancer cell line MDA-MB-361

Project description:DCD is a gene amplified and overexpressed in a subset of breast tumors acting as a growth and survival factor. Patients with DCD-positive breast cancer have worse prognostic features. To investigate the role of DCD in breast tumorigenesis, we analyzed the consequences of its downregulation in human breast cancer cell lines using three specific shRNA lentivirus vectors. Genes up- and down-regulated by DCD were identified using Affymetrix microarray and analyzed by MetaCore Platform. We found that loss of DCD expression led to reduced cell proliferation, resistance to apoptosis, and suppressed tumorigenesis in immunodeficient mice. Network analysis of gene expression data revealed perturbed ERBB signaling following DCD shRNA expression including changes in the expression of ERBB receptors and their ligands. These findings imply that DCD promotes breast tumorigenesis via modulating the activity of the ERBB signaling pathways. As ERBB signaling is also important for neural survival, HER2+ breast tumors may highjack DCD’s neural survival-promoting functions to promote tumorigenesis.

2015-08-12 | GSE57578 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data